ArticleInflammopharmacology2024

Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathways.

Qiong Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.